Page 49 - Read Online
P. 49

Page 28 of 44                            Jung et al. Soft Sci 2024;4:15  https://dx.doi.org/10.20517/ss.2024.02

                    [265]
               levels . With an advance of electronic systems and wearable technology, the same group developed
               wearable microneedle-based sensor arrays for real-time monitoring of various biomarkers, such as lactate
               and glucose, or alcohol and glucose in ISF biofluid [Figure 9L]. Reusability was enhanced using disposable
               MNA, electronics and optimized system integration. Through the comparison of gold-standard
               measurements in blood or breath, dual-analyte measurements using this system showed a good correlation
                                         [266]
               with a commercial technology . For more sophisticated metabolic profiling and monitoring, a universal
               wearable biosensing strategy using molecularly imprinted polymer (MIP)-based artificial antibodies was
               presented by Wang et al. [Figure 9M]. Autonomous and continuous molecular analysis was realized by
               incorporating iontophoresis-based sweat induction and microfluidic-based sweat sampling. Several human
               trials demonstrated the possibility of personalized monitoring of five essential or conditionally essential
                                                                                  [267]
               amino acids for central fatigue, standard dietary intake, and COVID-19 severity .

               Despite these promising developments, effectively using wearable DM monitoring systems still requires
               more optimization and validation to thoroughly assess their reliability, versatility, and accuracy. These
               detailed studies will determine how well non-invasive methods can monitor biomarkers in biofluids and
               will compare the non-invasive data with traditional blood glucose measurements. Other limitations with
               wearable approaches include inconsistent collection of biofluids, contamination on the electrode surface,
               and the performance changes due to various physiological factors (such as temperature and pH) on the
               accuracy of the readings.

               To enhance DM management, multiplexed analysis for the diabetes-related biomarkers, such as
               electrophysiological factors, insulin, ketone, alcohol, etc., can achieve a more comprehensive assessment of
               patient health than singular glucose measurement. Nevertheless, the implementation of multi-analyte
               sensing platforms entails several significant challenges, including the integration of different surface
               modifications and sensing modalities into a single wearable platform, the mitigation of analytical
               interference or cross-talk among different analytes, the necessity for receptor regeneration in bioaffinity-
               based assay methods, and the maximization of sensitivity for analytes in biofluids due to the lower
               concentration than blood. Consequently, future research should proceed in the direction of integrating
               glucose sensing with other novel analytes and skills for clinical use while overcoming these hurdles.


               Machine learning-based multiplexed analysis for diabetes mellitus and its complications
               In the evolving landscape of DM management, ML algorithms have emerged as a key technological
               advancement. Central to these algorithms is using extensive data sets to build predictive models, particularly
               vital in glucose monitoring applications. Wearable devices and CGM systems play a crucial role by
               providing the necessary input and output data. The process involves dividing this data into training and
               evaluation sets, which helps refine the model parameters and assess its performance. By harnessing
               sophisticated computational methodologies, there exists the prospect of substantially enhancing the
               management of DM, rendering it more individualized and attuned to the specific requirements of each
               patient. This entails the anticipation of prevailing glucose levels, prognostication of future trends, and the
               provision of informed recommendations for insulin administration. This section presents several ML
               techniques in glucose monitoring. The associated studies are summarized in [Table 7].


               Artificial neural network
               Artificial neural networks (ANN) have become a cornerstone in advancing DM monitoring, primarily due
               to their ability to model complex relationships within data. The structure of an ANN is inspired by the
               human brain, comprising layers of interconnected nodes or neurons. These include input layers, which
               receive data such as blood glucose levels, dietary information and physical activity, hidden layers where the
   44   45   46   47   48   49   50   51   52   53   54